Citigroup Maintains Buy on Medline, Lowers Price Target to $55
Medline Inc MDLN
$38.71
▲ +0.42%
(+$0.16)
Open
$38.43
Prev Close
$38.55
Day Range
$37.65 – $38.81
52W Range
$34.89 – $50.88
Market Cap
$49.54B
P/E (TTM)
51.28
Beta
1.14
EPS (TTM)
$1.19
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-12-17 |
| Shares Out. | 1,313,690,000 |
| Website | ir.medline.com/ ↗ |
| Phone | 13026365401 |
Medline Inc is a publicly traded company under the ticker symbol MDLN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
34 analysts (2026-05-01)
📰 Latest News for MDLN
Bernstein Maintains Outperform on Medline, Lowers Price Target to $54
BTIG Reiterates Buy on Medline, Maintains $55 Price Target
Earnings Scheduled For May 6, 2026
Medline Inc. 2026 Q1 - Results - Earnings Call Presentation
US FDA flags shortage of neurosurgical pads and sponges, expects disruption through 2026
Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript
FDA Announces Medline Recalls All Of Its Stock Keeping Units In Medline Branded Neuro Sponge Category With No Definite Market Re-Entry Date